Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$44.11 0.98 (2.27%)
2/9/2010 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AZN

Add Stock to Watchlist

What the Community Thinks

AstraZeneca plc (ADR) At A Glance

Current Price: $44.11
Last Trade Time: 2/9/2010 4:01 PM
Open: $44.27
Previous Close: $43.13
Daily Range: $43.67 - $44.57
52-Week Range: $29.96 - $50.70
Volume: 2,755,275
Market Cap: $63.87B
P/E Ratio: 10.27
Compare Our Special Broker Offers!

Stock Trends

AZN VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for AZN

More Headlines...

Top Bull Pitch

Recs

1

AstraZeneca plc (ADR) (AZN)

Avatar cecil97 (24.62) Submitted: 7/14/09 10:56 PM

H1N1 vaccine demand, low forward P/E, consistent earnings and generous dividend. Next earnings report is 7/30/09

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

AstraZeneca plc (ADR) (AZN)

Avatar KingPortu (27.95) Submitted: 10/29/07 2:34 PM

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 74 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AZN)

Avatar colddrink73 (90.07) Submitted: 1/15/10 8:36 AM : Outperform Start Price: $47.31 AZN Score: -0.21

I see some room for closing the gap created by the recent run of the S&P. Looking for this to pretty much stay with the market once it makes up the 15% current lag. Oh.... and a dividend over 4 does not hurt. But the main reason to pick this stock is they have some of the funniest side affects. I mean afterall who does not want to get the urge to gamble and have sex? Strip poker any one?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AZN)

Avatar richardrogers4 (65.05) Submitted: 11/24/09 8:49 AM : Outperform Start Price: $43.71 AZN Score: 4.31

Defensive large cap

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AZN)

Avatar wooderino (96.95) Submitted: 10/27/09 12:15 PM : Outperform Start Price: $44.69 AZN Score: -1.42

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AZN)

Avatar Hassjo (97.84) Submitted: 10/16/09 2:45 PM : Outperform Start Price: $42.72 AZN Score: 0.32

Huge demand for FluMist, sales/profits will be massive. Long Term outperform.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AZN)

Avatar NewlyMinted4Star (< 20) Submitted: 10/14/09 10:30 AM : Outperform Start Price: $42.85 AZN Score: 4.03

This account tracks the performance of newly minted 4 star stocks - 3 star stocks that recently turned in to 4 star stocks.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 74 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCollinsStew 68.03 09/29/09 Underperform NS $43.76+0.80%+0.67%-0.13
TrackEdwardOwens 98.91 08/12/09 Outperform 1Y $44.39-0.62%+8.21%-8.83 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 82.08 05/28/09 Underperform NS $38.86+13.51%+19.77%+6.26
TrackUBS 87.99 04/27/09 Outperform NS $34.47+27.95%+26.35%+1.61
TrackDeutscheSec 89.68 01/30/09 Outperform NS $35.21+25.28%+28.37%-3.10
TrackKevinDann 70.95 01/23/09 Outperform NS $36.24+21.73%+32.05%-10.32
TrackCowenandCo 86.76 10/29/08 Outperform NS $35.15+25.47%+17.86%+7.61
TrackHSBC 86.09 06/26/08 Underperform NS $39.31+12.22%-15.27%-27.49
TrackJPMorgan 84.76 04/18/08 Underperform NS $37.71+16.97%-19.72%-36.69
TrackJimCramer < 20 04/01/08 Outperform 3W $36.78+19.94%-18.61%+38.54
TrackBrandes < 20 09/30/07 Outperform NS $43.82+0.67%-26.38%+27.05 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 84.85 01/12/07 Outperform NS $47.69-7.51%-19.92%+12.41

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 250ms